000 | 01899 a2200505 4500 | ||
---|---|---|---|
005 | 20250514190450.0 | ||
264 | 0 | _c20040715 | |
008 | 200407s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.0400576101 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBosch, Berend Jan | |
245 | 0 | 0 |
_aSevere acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJun 2004 |
||
300 |
_a8455-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 |
_aMass Spectrometry _xmethods |
650 | 0 | 4 | _aMembrane Fusion |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aPeptides _xgenetics |
650 | 0 | 4 | _aProtein Structure, Quaternary |
650 | 0 | 4 | _aProtein Structure, Secondary |
650 | 0 | 4 |
_aSevere acute respiratory syndrome-related coronavirus _xgenetics |
650 | 0 | 4 | _aSequence Alignment |
650 | 0 | 4 |
_aSevere Acute Respiratory Syndrome _xdrug therapy |
650 | 0 | 4 | _aSpike Glycoprotein, Coronavirus |
650 | 0 | 4 | _aVero Cells |
650 | 0 | 4 |
_aViral Envelope Proteins _xgenetics |
700 | 1 | _aMartina, Byron E E | |
700 | 1 | _aVan Der Zee, Ruurd | |
700 | 1 | _aLepault, Jean | |
700 | 1 | _aHaijema, Bert Jan | |
700 | 1 | _aVersluis, Cees | |
700 | 1 | _aHeck, Albert J R | |
700 | 1 | _aDe Groot, Raoul | |
700 | 1 | _aOsterhaus, Albert D M E | |
700 | 1 | _aRottier, Peter J M | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 101 _gno. 22 _gp. 8455-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.0400576101 _zAvailable from publisher's website |
999 |
_c14859197 _d14859197 |